Dr. Reddy's ends Novartis India brand distribution deal

Major Contract CancelledBusiness Updates View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹1168.60

prior close

₹1172.00

announcement price

After-mkt

timing

Nifty 100market+0.1%-0.9% vs market

Pharmaceuticals peers, median of 165sector-0.1%-0.8% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty 100 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.2

15m

+0.1

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.1-0.9-0.1-0.8

Next day

+3.2-0.3+3.5+0.0+3.2

+2.3-0.4+2.7-0.1+2.4

+3.3-0.6+3.8+0.2+3.1

+2.7-0.7+3.4-0.6+3.3

+2.0-1.0+3.0-1.2+3.2

+0.1-1.8+1.9-2.0+2.1

15d

-1.2-1.9+0.6+0.2-1.4

-2.2-4.2+2.0+1.7-3.9

+5.2-8.9+14.1-2.0+7.3

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Reddy's has terminated its February 2022 agreement with Novartis India for distributing and promoting select brands in India. The termination follows a change in the controlling shareholding of Novartis India. Dr. Reddy's will continue to commercialize these brands until September 30, 2026.

Likely market impact

Loss of Novartis brand portfolio in India may pressure domestic revenue after September 2026 transition.